Side-by-side comparison of AI visibility scores, market position, and capabilities
Phoenix BC Partners-owned largest North American specialty pet retailer at $10B FY2023 revenue with 1,500+ stores, Banfield vet clinics, and Chewy equity stake competing with Petco and Chewy for pet care market share.
PetSmart is a Phoenix, Arizona-based specialty pet retail chain — privately held since BC Partners' $8.7 billion leveraged buyout in 2015 — operating 1,500+ stores across the United States, Canada, and Puerto Rico as the largest specialty pet retailer in North America, generating approximately $10 billion in revenue in fiscal year 2023 (with Q3 2024 sales of $1.50 billion, +8% year-over-year), serving pet owners with an integrated retail, services, and healthcare ecosystem that includes pet food and supplies, grooming salons, PetsHotel boarding and day camp, Banfield Pet Hospital veterinary clinics (an in-store Mars Inc. franchise), dog training classes, and adoption events partnering with local rescue organizations and shelters. PetSmart holds a significant equity stake in Chewy, Inc. (NYSE: CHWY), having acquired Chewy in 2017 for $3.35 billion before Chewy's 2019 IPO.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.